Apply AI to De-Risk Drug Discovery & Development

May 4, 2017
Deliver Better & More Cost Effective Medicines Faster

BOSTON, MA - May 8, 2017 - Unsustainable - The one word frequently used to describe traditional R&D. However, AI technologies are going to change that. AI is driving innovation in drug development, promising expedited timelines, identification of better drug candidates and ultimately a greater improvement of R&D productivity.

AI Pharma Innovation 2017 (BOSTON, July 25-27) is the only industry event dedicated to help large pharma and biotech drug developers strategically adopt & effectively apply next generation AI technologies to de-risk drug development, enhance R&D productivity and deliver better medicines to patients faster.

Here’s what you can expect to get from the event:

  • Understand the differences and values of multiple AI algorithms with insight from Numerate and Sanofi  and scope the potential benefit that these different algorithms can bring to numerous facets along the R&D pipeline
  • Access real world case studies and lessons learned from discovery through to clinical development from the likes of Genentech, Recursion Pharmaceuticals, MSD, Biogen and Boehringer Ingelheim
  • Get the Novartis  and Takeda perspectives on overcoming cultural and infrastructure barriers to streamline the integration and operation of an AI approach in your company

View the full event programme here: http://ai-pharma.com/event-guide/

Our rock star speaker line-up includes the likes of:

  • David Christie, Vice President, Research & Development Informatics, Amgen
  • Ryad Ali, Global Head, Disruptive Technologies, Novartis
  • Kaushik Raha, Head, Emerging Analytics & Advanced Visualizations, Data Sciences, Janssen
  • Jason Raines, Head, Biometrics Data Sciences & Operations, Biogen
  • Ranga Sarangarajan, Senior Vice President & CSO, Berg Health
  • Shahar Keinan, CSO, Cloud Pharmaceuticals

View full speaker line-up here: http://ai-pharma.com/event-guide/

Join experts and leaders from large pharma, biotech, technology companies and academic institutions who are all capitalizing on AI technologies to boost innovation and make smarter decisions throughout R&D. Discover the customized technology solutions you need and overcome the cultural, technical integration and strategic challenges in order to extract the value promised by AI.

Find out more at www.ai-pharma.com 

Register before May 12 to benefit from discount rates.